Literature DB >> 19452241

Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus.

Yoshie Sasatomi1, Hidetoshi Kaneoka2, Yasuhiro Abe2, Atunori Ishimura2, Satoru Ogahara2, Toshiaki Murata2, Noriko Uesugi3, Shigeo Takebayashi3, Hiroshi Iwasaki3, Takao Saito2.   

Abstract

BACKGROUND: Diabetic nephrosclerosis is the most common cause of renal failure in the industrialized countries. At the same time, the mortality rate of patients with diabetes mellitus is high.
METHODS: To clarify the factors influencing the prognosis and survival of patients with diabetic nephrosclerosis, we carried out a retrospective follow-up study of 166 cases (age, 55.6 +/- 1.0 years; male/female, 110/56) by simple and multifactorial analyses of clinical data recorded at time of renal biopsy, including survival after diagnosis of diabetic mellitus (months), body mass index (BMI) (kg/m(2)) [body weight/(body height)(2)], age (years), mean blood pressure (mBP) (mmHg) [diastolic BP + (systolic BP - diastolic BP)/3], serum levels of albumin (mg/dl), urea nitrogen (BUN) (mg/dl), serum creatinine (s-Cr) (mg/dl), total cholesterol (mg/dl), triglyceride (mg/dl), and fasting blood sugar (FBS) (mg/dl), hematocrit (%), HbA1c (%), urinary protein secretion (g/day), insulin resistance, BP control (good, <140/90 mmHg or poor, > or =140/90 mmHg) after biopsies, and pathomorphological parameters at the biopsy.
RESULTS: We found a significant association between renal prognosis and several factors, e.g., hypoalbuminemia, anemia, high levels of BUN and s-Cr, hypercholesteremia, hypertriglyceridemia at biopsy, poor control of BP after biopsies, Kimmelstiel-Wilson nodule, and severe glomerular and tubulointerstitial damages at the biopsy. In addition, associations between survival and factors such as low value of BMI, elderly age at the biopsy, and poor control of BP after biopsies were significant. By multivariate analysis we also found a significant association of renal prognosis with anemia, BUN, severe glomerular damage at the biopsy, and poor control of BP after biopsies. At the same time, poor control of BP after biopsies had a significant association with survival. On Kaplan-Meier analysis, anemia at biopsy and hypertension after biopsies are risk factors for both renal prognosis and survival in diabetes mellitus patients.
CONCLUSIONS: Our data strongly suggest that good control of BP after biopsies and anemia at the biopsy play pivotal roles in the prognosis and survival of patients with diabetic glomerulosclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19452241     DOI: 10.1007/s10157-009-0191-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  42 in total

1.  Diabetic nephropathy: a clinical and pathologic study based on renal biopsies.

Authors:  D D GELLMAN; C L PIRANI; J F SOOTHILL; R C MUEHRCKE; R M KARK
Journal:  Medicine (Baltimore)       Date:  1959-12       Impact factor: 1.889

2.  The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.

Authors:  D Ellis; C Lloyd; D J Becker; K Y Forrest; T J Orchard
Journal:  Am J Kidney Dis       Date:  1996-06       Impact factor: 8.860

3.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

4.  [Diabetic nephropathy: risk factors of rapid progression of renal failure].

Authors:  M V Shestakova; L A Chugunova; M Sh Shamkhalova; Iu A Dirochka; I I Dedov
Journal:  Ter Arkh       Date:  1999       Impact factor: 0.467

5.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

7.  Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy.

Authors:  S Inomata; M Itoh; H Imai; T Sato
Journal:  Nephron       Date:  1997       Impact factor: 2.847

8.  A light microscopic study of glomerulosclerosis in Japanese patients with noninsulin-dependent diabetes mellitus: the relationship between clinical and histological features.

Authors:  Y Suzuki; M Ueno; H Hayashi; S Nishi; H Satou; R Karasawa; H Inn; S Suzuki; Y Maruyama; M Arakawa
Journal:  Clin Nephrol       Date:  1994-09       Impact factor: 0.975

9.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

10.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  3 in total

1.  Chronic kidney disease and associated cardiovascular risk factors in chinese with type 2 diabetes.

Authors:  Qing-Lin Lou; Xiao-Jun Ouyang; Liu-Bao Gu; Yong-Zhen Mo; Ronald Ma; Jennifer Nan; Alice Kong; Wing-Yee So; Gary Ko; Juliana Chan; Chun-Chung Chow; Rong-Wen Bian
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

2.  Interrelationship of βeta-2 microglobulin, blood urea nitrogen and creatinine in streptozotocin-induced diabetes mellitus in rabbits.

Authors:  Shahram Javadi; Siamak Asri-Rezaei; Maryam Allahverdizadeh
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

3.  BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease.

Authors:  Saideh Fakharzadeh; Hassan Argani; Simin Dadashzadeh; Somayeh Kalanaky; Peyman Mohammadi Torbati; Mohammad Hassan Nazaran; Abbas Basiri
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-17       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.